PARIETEX
Report
- Report Number
- 9615742-2024-01293
- Event Type
- Injury
- Date Received
- September 10, 2024
- Report Date
- September 10, 2024
- Manufacturer
- SOFRADIM PRODUCTION SAS
- Product Code
- FTL
- PMA / PMN Number
- K173796
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- 003
Narratives
D10 (BARD PERMAFIX FIXATION 36 CM X2, PRODUCT ID - 0113120, LOT # - HUWG0955). MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
THE PATIENT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. THE PRODUCT WAS USED FOR THERAPEUTIC TREATMENT OF AN INCISIONAL HERNIA. IT WAS REPORTED THAT AFTER IMPLANT, THE PATIENT EXPERIENCED HERNIA RECURRENCE, DIVARICATION OF THE RECTI, FLUID COLLECTION, LABS ABNORMAL FOR CRP, ATROPHIC LATERAL MUSCLES, DISCOMFORT, ADHESIONS, FEVER, SEROMA, ANXIETY, EMESIS, OPEN WOUND WITH BLEEDING, INFLAMMATION WITH SWELLING, UNABLE TO HAVE BOWEL MOTION, DIAPHORETIC, PAIN, <(>&<)> ABDOMINAL PAIN. POST OPERATIVE TREATMENT INCLUDED HERNIA REPAIR WITH NEW MESH, CT SCAN, HOSPITALIZATION, EXCESS SAC EXCISED, ANTIBIOTICS, EPIDURAL PCA, ORAL PAIN MEDICATION, IV FLUIDS, ANTIEMETICS, DIAZEPAM, WOUND CARE, <(>&<)> PHYSIOTHERAPY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2329385 | PARIETEX | MESH, SURGICAL, POLYMERIC | FTL | SOFRADIM PRODUCTION SAS | PCO3728FX | PND0528 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Hospitalization| R | SEE H11 COMMENT |